Volumetric and texture analysis of pretherapeutic (18)F-FDG PET can predict overall survival in medullary thyroid cancer patients treated with Vandetanib

PURPOSE: The metabolically most active lesion in 2-deoxy-2-((18)F)fluoro-D-glucose ((18)F-FDG) PET/CT can predict progression-free survival (PFS) in patients with medullary thyroid carcinoma (MTC) starting treatment with the tyrosine kinase inhibitor (TKI) vandetanib. However, this metric failed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Rudolf A., Bundschuh, Ralph A., Higuchi, Takahiro, Javadi, Mehrbod S., Rowe, Steven P., Zsótér, Norbert, Kroiss, Matthias, Fassnacht, Martin, Buck, Andreas K., Kreissl, Michael C., Lapa, Constantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394453/
https://www.ncbi.nlm.nih.gov/pubmed/30206772
http://dx.doi.org/10.1007/s12020-018-1749-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394453/
https://www.ncbi.nlm.nih.gov/pubmed/30206772
http://dx.doi.org/10.1007/s12020-018-1749-3

Ejemplares similares